On July 18, 2024, Biodexa Pharmaceuticals Plc entered agreements to raise approximately $3.0 million through the sale of 5,050,808 American Depositary Shares at $0.94 each and 278,975 pre-funded warrants. These transactions are expected to close by July 22, 2024.